The biggest drop is 81%!

The largest drop reached 81%.
On March 17, the Sichuan Provincial Medical Insurance Bureau announced that following the implementation of the results of the procurement of coronary stents and coronary dilation balloons, the bureau continued to promote the centralized procurement of inter-provincial alliances.
With the method of “volume linkage and two-way selection”, the centralized procurement of intraocular lens, coronary drug balloon and pacemaker medical consumables organized by the inter-provincial alliance has been completed, and the prices of the three types of consumables have been greatly reduced.
The selected products have the largest drop of over 80%.

.
Among them, the selected results of coronary drug balloon and pacemaker centralized collection have been implemented on January 30, 2022 and February 16, 2022, respectively, and the intraocular lens has also landed in Sichuan on March 7, 2022
.
It is reported that the average price of coronary drug balloons has dropped from 22,000 yuan to 6,300 yuan in this volume purchase, a price drop of more than 71%, and the largest drop of 81%.
According to the demand measurement in Sichuan Province, it is estimated that the annual procurement cost will be saved by about 7,600 yuan.
RMB 10,000; the average price of pacemakers dropped from RMB 48,000 to RMB 24,000, a drop of 50%, with a maximum drop of 81%.
It is expected to save about RMB 139 million in purchasing costs each year; the average price of intraocular lenses dropped from RMB 4,112 to RMB 2,347 , the decline is 43%, and the largest decline is 78%.
It is estimated that the annual purchase cost will be saved by more than 240 million yuan
.
After the centralized procurement, the price of relevant medical consumables in Sichuan is at a low level in the country
.
Up to now, Sichuan Province has purchased medical consumables in large quantities, covering coronary stents, coronary dilation balloons, coronary drug balloons, pacemakers and intraocular lenses
.
At present, the procurement of high-value consumables has entered a new stage of normalization and institutionalization
.
The centralized procurement of high-value medical consumables focuses on cardiology and orthopedics, two areas that are most concerned by the public.
The centralized procurement of cardiac stents has been in operation for a year, and the total number of selected stents is 1.
69 million sets, reaching 1.
6 times the annual agreement procurement volume
.
In 2021, the state will carry out centralized and quantity procurement organized by the state for more complex orthopaedic consumables
.
From the current point of view, the procurement of national organizations and alliances has formed a normalized pattern
.
Chen Jinfu, deputy director of the National Medical Security Administration, pointed out at the State Council policy briefing earlier this year that the average price of cardiac stents has dropped by 93%, and the average price of artificial hip and knee joints has been reduced by 82%, squeezing the space for false heights
.
Judging from the cumulative results of the three-year reform, the state organized centralized procurement to save more than 260 billion yuan
.
Taking heart stents as an example, 1/3 of the stents used to be stainless steel, but now they are basically eliminated, and the utilization rate of the selected chrome alloy has reached 95%
.
After the front wave passed, the back wave aimed at orthopaedics and intraocular lenses
.
On March 9, the "Beijing-Tianjin-Hebei "3+N" Alliance Orthopedic Trauma Medical Consumables and Quantity Linked Procurement Result Notice" was released, involving 17 provinces and autonomous regions
.
The lowest price selected is 5.
51 yuan (shallow thread screw-2), and the highest is 2059.
96 yuan (with intramedullary nails)
.
Different from the previous purchase with quantity, this time the purchase is "link with quantity"
.
That is, according to the use needs of the purchasing entity, with reference to the overall market price level, comprehensive quality and other factors, link the purchase price of orthopaedic trauma medical consumables alliance in Henan and other 12 provinces with volume, and through mutual selection between buyers and sellers, the selected products are determined and subcontracted according to the volume.
, the implementation of linked procurement with quantity
.
In September last year, the 12-province alliance in Henan announced the purchase price with volume
.
In the end, 20,751 products from 71 companies were selected, with an average drop of 88.
65%
.
Among them, the price of ordinary bone plate system dropped from an average of about 4,683 yuan to about 606 yuan, an average decrease of 87.
05%; the price of a locking (universal) compression plate system dropped from an average of about 9,360 yuan to about 987 yuan, an average decrease of 89.
45%; The price of intramedullary nail system dropped from an average of about 11,687 yuan to about 1,271 yuan, an average decrease of 89.
12%
.
The same is the Beijing-Tianjin-Hebei pharmaceutical joint procurement platform
.
It also recently released the "Notice on Announcement of the Results of the Beijing-Tianjin-Hebei "3+N" Alliance IOL-based Medical Consumables with Volume Linkage Procurement", which also requires that within the procurement cycle, if the selected price for procurement in other regions is higher than this time with volume If the price selected in the linkage procurement is low, the price linkage will be implemented
.
On November 24, 2021, the Beijing-Tianjin-Hebei "3+N" alliance started the procurement of intraocular lenses (except hard crystals) with quantity
.
The main procurement entities are public medical institutions with records of purchasing intraocular lens medical consumables in 14 provinces (autonomous regions and municipalities directly under the Central Government) in Beijing, Tianjin, Hebei, Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, Shandong, Sichuan, Chongqing, Tibet, Henan and Guizhou in 2020.
Institutions (including military medical institutions), the procurement cycle is 1 year
.
At the end of April 2020, there was a joint procurement of intraocular lens medical consumables by the 9 provinces of Beijing, Tianjin and Hebei
.
On May 22, 2020, the announcement of the selection results of joint volume procurement showed that a total of 44 products from 19 companies were selected, and the average drop of intraocular lenses was 53.
72%, and the highest drop was 84.
21%
.
Among them are Johnson & Johnson Vision Health, Nidec Co.
, Ltd.
, Airui Technology Corporation, Human Optical Co.
, Ltd.
,
etc.
As of October 2020, a total of 22 provinces across the country have completed 5 purchases of intraocular lens tapes, with price reductions ranging from 18% to 85%
.
At present, a number of large-scale inter-provincial alliances have been established: Beijing-Tianjin-Hebei "3+N" alliance, Guangdong and other 16 provincial alliances, eight provinces and two districts, and Sanming procurement alliance.
.
.
According to the trend of centralized procurement, the alliance will continue to increase the amount of procurement.
Expand, the price will gradually realize the national linkage
.
Regarding the direction of centralized procurement in the next step, Chen Jinfu, deputy director of the National Medical Security Administration, said that the procurement of drugs and high-value medical consumables will be carried out in a normalized and institutionalized manner
.
On the one hand, consolidate the new normal, and promote the acceleration of centralized procurement and expansion
.
High-value medical consumables focus on orthopedic consumables, drug balloons, dental implants and other varieties, and strive to achieve an average coverage of more than 350 drug varieties per province by the end of 2022 through national organizations and provincial alliance procurement, high-value medical consumable varieties Reach more than 5, making it the new normal for centralized purchases
.
Regarding the centralized procurement of orthopedic consumables, drug balloons, dental implants and other consumables, Chen Jinfu made it clear that this year, it will be further extended to spinal consumables, so that orthopedic consumables basically reach the main body coverage
.
Thorough research on spinal consumables and standardization of information, including rules, are underway
.
The state represents the national provincial-level alliance, and organizes the procurement of certain varieties.
The Shanghai Pharmaceutical Office operates the medicines, and the Tianjin Pharmaceutical Purchasing Center operates the consumables.
In fact, the main body of the alliance is still the province
.
Under this line of thinking, a large number of new varieties will be recruited through provincial-level alliances in the future, and even third-party recruiting.
The seemingly complicated market will become clearer and clearer, and the price line will become more and more low.
transparent
.